IL137004A0 - Crystallographically stable amorphous cephalosporin compositions and process for producing the same - Google Patents

Crystallographically stable amorphous cephalosporin compositions and process for producing the same

Info

Publication number
IL137004A0
IL137004A0 IL13700499A IL13700499A IL137004A0 IL 137004 A0 IL137004 A0 IL 137004A0 IL 13700499 A IL13700499 A IL 13700499A IL 13700499 A IL13700499 A IL 13700499A IL 137004 A0 IL137004 A0 IL 137004A0
Authority
IL
Israel
Prior art keywords
producing
same
stable amorphous
crystallographically stable
cephalosporin compositions
Prior art date
Application number
IL13700499A
Other languages
English (en)
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of IL137004A0 publication Critical patent/IL137004A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13700499A 1998-01-07 1999-01-07 Crystallographically stable amorphous cephalosporin compositions and process for producing the same IL137004A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP192098 1998-01-07
PCT/JP1999/000020 WO1999034832A1 (fr) 1998-01-07 1999-01-07 Compositions de cephalosporine amorphes, stables du point de vue cristallographique et procede de preparation de ces compositions

Publications (1)

Publication Number Publication Date
IL137004A0 true IL137004A0 (en) 2001-06-14

Family

ID=11515039

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13700499A IL137004A0 (en) 1998-01-07 1999-01-07 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
IL137004A IL137004A (en) 1998-01-07 2000-06-26 Amorphous cephalosporin preparations are crystallographically stable and a method for their production

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL137004A IL137004A (en) 1998-01-07 2000-06-26 Amorphous cephalosporin preparations are crystallographically stable and a method for their production

Country Status (23)

Country Link
US (2) US6342493B1 (uk)
EP (1) EP1051978B1 (uk)
JP (1) JP3413406B2 (uk)
KR (1) KR100435315B1 (uk)
CN (1) CN1151845C (uk)
AU (1) AU736555B2 (uk)
BR (1) BRPI9907084B8 (uk)
CA (1) CA2316841C (uk)
CZ (1) CZ302082B6 (uk)
EA (1) EA002881B1 (uk)
ES (1) ES2393972T3 (uk)
HK (1) HK1035148A1 (uk)
HU (1) HU230295B1 (uk)
ID (1) ID25469A (uk)
IL (2) IL137004A0 (uk)
NZ (1) NZ505871A (uk)
PL (1) PL194097B1 (uk)
PT (1) PT1051978E (uk)
SK (1) SK286631B6 (uk)
TR (1) TR200001903T2 (uk)
TW (1) TW587946B (uk)
UA (1) UA70311C2 (uk)
WO (1) WO1999034832A1 (uk)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL194097B1 (pl) * 1998-01-07 2007-04-30 Meiji Seika Kaisha Kompozycja zawierająca krystalograficznie trwałą amorficzną cefalosporynę i sposób jej wytwarzania
CZ302015B6 (cs) 1999-10-08 2010-09-08 Affinium Pharmaceuticals, Inc. Inhibitory Fab I
ATE420640T1 (de) 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
AU2002253642B2 (en) * 2001-04-26 2007-05-24 Meiji Seika Kaisha, Ltd. Amorphous cefditoren pivoxil composition and process for producing the same
CA2500712C (en) * 2002-10-02 2011-08-09 Meiji Seika Kaisha, Ltd. Antibiotic pharmaceutical composition with improved oral absorbability
DK1575951T3 (da) 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
EP1608377B1 (en) * 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
WO2004113451A1 (ja) * 2003-06-20 2004-12-29 Meiji Seika Kaisha, Ltd. 難溶性物質と水溶性高分子との共沈物およびその製造方法
ATE539738T1 (de) 2003-10-08 2012-01-15 Meiji Seika Pharma Co Ltd Nichtkristalline antibakterielle zusammensetzung mit cefditoren-pivoxil
WO2005044824A2 (en) * 2003-11-07 2005-05-19 Ranbaxy Laboratories Limited Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin
JP2005162696A (ja) * 2003-12-04 2005-06-23 Nichiko Pharmaceutical Co Ltd 溶出性に優れたセフジトレンピボキシル製剤
WO2005082330A2 (en) * 2004-02-19 2005-09-09 Ranbaxy Laboratories Limited Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same
SI1828167T1 (sl) 2004-06-04 2014-12-31 Debiopharm International Sa Forum "Apres-Demain" Akrilamidni derivati kot anitibiotična sredstva
US20080069879A1 (en) * 2006-05-02 2008-03-20 Ravishekhar Bhiwgade Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
WO2008057058A1 (en) * 2006-11-10 2008-05-15 Nobel Ilac Sanayii Ve Ticaret As Oral pharmaceutical compositions
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
CN101560216B (zh) * 2009-05-27 2011-06-15 上海交通大学 头孢妥仑酯的制备方法
WO2012010938A2 (en) * 2010-07-23 2012-01-26 Lupin Limited Pharmaceutical compositions of cefditoren pivoxil
SI2623498T1 (sl) 2010-09-30 2016-03-31 Toyama Chemical Co., Ltd. Natrijeva sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida
JP5936546B2 (ja) 2010-09-30 2016-06-22 富山化学工業株式会社 ６−フルオロ−３−ヒドロキシ−２−ピラジンカルボキサミドのメグルミン塩
MX356695B (es) 2012-06-19 2018-06-11 Debiopharm Int Sa Profarmacos derivados de (e)-n-metil-n-((3-metilbenzofuran-2-il)me til)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il) acrilamida.
EP3039011A1 (en) * 2013-08-29 2016-07-06 Cadila Healthcare Limited Polymorphic form of pyrrole derivative and intermediate thereof
WO2016114727A1 (en) 2015-01-16 2016-07-21 Öğün Yusuf Toktamiş Cefditoren pivoxil compositions with improved stability and production methods thereof
KR20180114177A (ko) 2016-02-26 2018-10-17 데비오팜 인터네셔날 에스 에이 당뇨병성 족부 감염의 치료제
CN109053768A (zh) * 2018-08-07 2018-12-21 中国医药集团总公司四川抗菌素工业研究所 一种无定型头孢妥仑酯的制备方法
CN110251467A (zh) * 2019-06-26 2019-09-20 北京济美堂医药研究有限公司 一种无定形态头孢妥仑匹酯组合物的制备方法
CN112190539B (zh) * 2020-11-10 2021-11-02 深圳立健药业有限公司 一种头孢妥仑匹酯组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0678234B2 (ja) * 1988-04-19 1994-10-05 明治製菓株式会社 経口投与用抗菌組成物
JPH05306227A (ja) * 1992-04-27 1993-11-19 Lion Corp 徐放性口腔内疾患治療剤
JP2576927B2 (ja) * 1992-05-15 1997-01-29 ファイザー製薬株式会社 細粒核
JPH06316517A (ja) * 1993-02-22 1994-11-15 Grelan Pharmaceut Co Ltd 放出制御製剤
JPH0717866A (ja) * 1993-06-16 1995-01-20 Meiji Seika Kaisha Ltd 医薬組成物
AR004014A1 (es) * 1995-10-13 1998-09-30 Meiji Seika Kaisha Una composicion antibacteriana de cefditoren pivoxilo para administracion oral y metodo para obtener dicha composicion
NZ334883A (en) * 1996-09-20 2000-09-29 Meiji Seika Kaisha A crystalline substance of cefditoren pivoxil which has desirable thermal storage stability and the production of the same
PL194097B1 (pl) * 1998-01-07 2007-04-30 Meiji Seika Kaisha Kompozycja zawierająca krystalograficznie trwałą amorficzną cefalosporynę i sposób jej wytwarzania

Also Published As

Publication number Publication date
TW587946B (en) 2004-05-21
UA70311C2 (uk) 2004-10-15
EA200000742A1 (ru) 2001-02-26
BR9907084A (pt) 2000-10-17
ES2393972T8 (es) 2013-02-25
WO1999034832A8 (fr) 1999-10-28
EP1051978A4 (en) 2007-05-02
BRPI9907084B8 (pt) 2021-05-25
TR200001903T2 (tr) 2000-11-21
CZ302082B6 (cs) 2010-09-29
SK10262000A3 (sk) 2001-01-18
ES2393972T3 (es) 2013-01-03
IL137004A (en) 2008-11-03
HU230295B1 (hu) 2015-12-28
EA002881B1 (ru) 2002-10-31
EP1051978B1 (en) 2012-08-22
WO1999034832A1 (fr) 1999-07-15
SK286631B6 (sk) 2009-02-05
AU1784599A (en) 1999-07-26
BRPI9907084B1 (pt) 2017-04-25
PL341589A1 (en) 2001-04-23
CN1290177A (zh) 2001-04-04
US6342493B1 (en) 2002-01-29
CN1151845C (zh) 2004-06-02
HUP0101272A2 (hu) 2001-12-28
AU736555B2 (en) 2001-08-02
US20020037322A1 (en) 2002-03-28
CA2316841C (en) 2007-11-20
EP1051978A1 (en) 2000-11-15
US6486149B2 (en) 2002-11-26
PT1051978E (pt) 2012-11-20
KR20010033961A (ko) 2001-04-25
ID25469A (id) 2000-10-05
CZ20002542A3 (cs) 2000-12-13
KR100435315B1 (ko) 2004-06-10
CA2316841A1 (en) 1999-07-15
JP3413406B2 (ja) 2003-06-03
HK1035148A1 (en) 2001-11-16
NZ505871A (en) 2002-10-25
HUP0101272A3 (en) 2002-07-29
PL194097B1 (pl) 2007-04-30

Similar Documents

Publication Publication Date Title
IL137004A0 (en) Crystallographically stable amorphous cephalosporin compositions and process for producing the same
HUP0100215A3 (en) Process for the preparation of substantially amorphous alpha-ol
GB2354765B (en) Dispersion composition and method for producing the same
AU1303801A (en) Transplant material and process for producing the same
EP1174484A4 (en) WATER AND OIL REPELLENT COMPOSITION AND METHOD FOR PRODUCING THE SAME
EP1114836A4 (en) RESIN-BASED COMPOSITION AND PROCESS FOR PRODUCING THE SAME
SG87108A1 (en) Monofilament and process for producing the same
HUP0104412A3 (en) Compositions comprising cefuroxime axetil and process for their preparation
HU0800266D0 (en) Amorphous ritonavir and process for the preparation of the polymorphous form i the same
IL129906A0 (en) Process for the preparation of beta-isophorone
HUP0004505A3 (en) Novel substances kf-1040 and process for producing the same
AU1306601A (en) Chemically modified supports and process for producing the same
AU2002253642A1 (en) Amorphous cefditoren pivoxil composition and process for producing the same
AU7416700A (en) Insulating shaped body and method for producing the same
EP1389462A4 (en) AMORPHIC CEFIDITIVE PIVOXIL COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
EP1253168A4 (en) ADDITIVE COMPOSITION FOR RESINS AND PROCESS FOR PRODUCING THE SAME
AU1979999A (en) Process for the preparation of cefuroxime axetil in an amorphous form
AU2002212688A1 (en) Amorphous coke for special carbonaceous material and process for producing the same
EP1016682A4 (en) TETRACYCLODODECES COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
HUP0201508A2 (en) Granular water-dispersible agents and process for producing the same
AU2001264385A1 (en) Novel cephalosporin compounds and process for preparing the same
EP1142954A4 (en) RESIN COMPOSITIONS AND METHODS OF MAKING THEM
EP1160330A4 (en) SUBSTANCES WK-5344A AND WK-5344B AND METHOD FOR THE PRODUCTION THEREOF
AU2596500A (en) Method for the production of arylsulfides and compositions made therefrom
EP1120100A4 (en) ANTIBACTERIAL AGENTS AND THEIR PREPARATION PROCESS